Cargando…

Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area

Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gramantieri, Laura, Gnudi, Federica, Vasuri, Francesco, Mandrioli, Daniele, Fornari, Francesca, Tovoli, Francesco, Suzzi, Fabrizia, Vornoli, Andrea, D’Errico, Antonia, Piscaglia, Fabio, Giovannini, Catia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024438/
https://www.ncbi.nlm.nih.gov/pubmed/35458213
http://dx.doi.org/10.3390/nu14081652
_version_ 1784690588341239808
author Gramantieri, Laura
Gnudi, Federica
Vasuri, Francesco
Mandrioli, Daniele
Fornari, Francesca
Tovoli, Francesco
Suzzi, Fabrizia
Vornoli, Andrea
D’Errico, Antonia
Piscaglia, Fabio
Giovannini, Catia
author_facet Gramantieri, Laura
Gnudi, Federica
Vasuri, Francesco
Mandrioli, Daniele
Fornari, Francesca
Tovoli, Francesco
Suzzi, Fabrizia
Vornoli, Andrea
D’Errico, Antonia
Piscaglia, Fabio
Giovannini, Catia
author_sort Gramantieri, Laura
collection PubMed
description Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas.
format Online
Article
Text
id pubmed-9024438
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90244382022-04-23 Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area Gramantieri, Laura Gnudi, Federica Vasuri, Francesco Mandrioli, Daniele Fornari, Francesca Tovoli, Francesco Suzzi, Fabrizia Vornoli, Andrea D’Errico, Antonia Piscaglia, Fabio Giovannini, Catia Nutrients Article Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas. MDPI 2022-04-15 /pmc/articles/PMC9024438/ /pubmed/35458213 http://dx.doi.org/10.3390/nu14081652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Gramantieri, Laura
Gnudi, Federica
Vasuri, Francesco
Mandrioli, Daniele
Fornari, Francesca
Tovoli, Francesco
Suzzi, Fabrizia
Vornoli, Andrea
D’Errico, Antonia
Piscaglia, Fabio
Giovannini, Catia
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title_full Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title_fullStr Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title_full_unstemmed Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title_short Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
title_sort aflatoxin b1 dna-adducts in hepatocellular carcinoma from a low exposure area
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024438/
https://www.ncbi.nlm.nih.gov/pubmed/35458213
http://dx.doi.org/10.3390/nu14081652
work_keys_str_mv AT gramantierilaura aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT gnudifederica aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT vasurifrancesco aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT mandriolidaniele aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT fornarifrancesca aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT tovolifrancesco aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT suzzifabrizia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT vornoliandrea aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT derricoantonia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT piscagliafabio aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea
AT giovanninicatia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea